MSDL 📈 Morgan Stanley Direct - Overview
Exchange: NYSE • Country: USA • Currency: USD • Type: Common Stock •
MSDL: Loans, Debt, Corporate, Finance, Investments
Additional Sources for MSDL Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MSDL Stock Overview
Market Cap in USD | 1,850m |
GiC Sub-Industry | Diversified Financial Services |
IPO / Inception | 2024-01-24 |
MSDL Stock Ratings
Growth 5y | 32.2% |
Fundamental | 26.5% |
Dividend | 52.7% |
Rel. Strength Industry | -66.9 |
Analysts | 3/5 |
Fair Price Momentum | 21.19 USD |
Fair Price DCF | 24.11 USD |
MSDL Dividends
Dividend Yield 12m | 10.56% |
Yield on Cost 5y | 11.54% |
Annual Growth 5y | 0.00% |
Payout Consistency | 100.0% |
MSDL Growth Ratios
Growth Correlation 3m | 84.8% |
Growth Correlation 12m | 24.7% |
Growth Correlation 5y | 24.7% |
CAGR 5y | 9.29% |
CAGR/Mean DD 5y | 1.30 |
Sharpe Ratio 12m | 0.30 |
Alpha | -6.29 |
Beta | 0.52 |
Volatility | 22.33% |
Current Volume | 474.2k |
Average Volume 20d | 418.3k |
What is the price of MSDL stocks?
As of December 22, 2024, the stock is trading at USD 20.84 with a total of 474,200 shares traded.
Over the past week, the price has changed by -1.61%, over one month by +1.76%, over three months by +6.55% and over the past year by +9.29%.
As of December 22, 2024, the stock is trading at USD 20.84 with a total of 474,200 shares traded.
Over the past week, the price has changed by -1.61%, over one month by +1.76%, over three months by +6.55% and over the past year by +9.29%.
Is Morgan Stanley Direct a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Morgan Stanley Direct is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.46 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MSDL as of December 2024 is 21.19. This means that MSDL is currently overvalued and has a potential downside of 1.68%.
Neither. Based on ValueRay Fundamental Analyses, Morgan Stanley Direct is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.46 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MSDL as of December 2024 is 21.19. This means that MSDL is currently overvalued and has a potential downside of 1.68%.
Is MSDL a buy, sell or hold?
Morgan Stanley Direct has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold MSDL.
Morgan Stanley Direct has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold MSDL.
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecast for MSDL stock price target?
According to ValueRays Forecast Model, MSDL Morgan Stanley Direct will be worth about 23.2 in December 2025. The stock is currently trading at 20.84. This means that the stock has a potential upside of +11.37%.
According to ValueRays Forecast Model, MSDL Morgan Stanley Direct will be worth about 23.2 in December 2025. The stock is currently trading at 20.84. This means that the stock has a potential upside of +11.37%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 21.1 | 1.2% |
Analysts Target Price | 21.4 | 2.6% |
ValueRay Target Price | 23.2 | 11.4% |